Cargando…

L-Cysteine Modified Chitosan Nanoparticles and Carbon-Based Nanostructures for the Intranasal Delivery of Galantamine

The present study evaluates the use of thiolized chitosan conjugates (CS) in combination with two fundamental carbon nanoforms (carbon dots (CDs) and Hierarchical Porous Carbons (HPC)) for the preparation of intranasally (IN) administrated galantamine (GAL) nanoparticles (NPs). Initially, the modifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nanaki, Stavroula G., Spyrou, Konstantinos, Veneti, Pelagia, Karouta, Niki, Gournis, Dimitrios, Baroud, Turki N., Barmpalexis, Panagiotis, Bikiaris, Dimitrios N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571213/
https://www.ncbi.nlm.nih.gov/pubmed/36235952
http://dx.doi.org/10.3390/polym14194004
_version_ 1784810308795105280
author Nanaki, Stavroula G.
Spyrou, Konstantinos
Veneti, Pelagia
Karouta, Niki
Gournis, Dimitrios
Baroud, Turki N.
Barmpalexis, Panagiotis
Bikiaris, Dimitrios N.
author_facet Nanaki, Stavroula G.
Spyrou, Konstantinos
Veneti, Pelagia
Karouta, Niki
Gournis, Dimitrios
Baroud, Turki N.
Barmpalexis, Panagiotis
Bikiaris, Dimitrios N.
author_sort Nanaki, Stavroula G.
collection PubMed
description The present study evaluates the use of thiolized chitosan conjugates (CS) in combination with two fundamental carbon nanoforms (carbon dots (CDs) and Hierarchical Porous Carbons (HPC)) for the preparation of intranasally (IN) administrated galantamine (GAL) nanoparticles (NPs). Initially, the modification of CS with L-cysteine (Cys) was performed, and the successful formation of a Cys-CS conjugates was verified via (1)H-NMR, FTIR, and pXRD. The new Cys-CS conjugate showed a significant solubility enhancement in neutral and alkaline pH, improving CS’s utility as a matrix-carrier for IN drug administration. In a further step, drug-loaded NPs were prepared via solid-oil–water double emulsification, and thoroughly analyzed by SEM, DLS, FTIR and pXRD. The results showed the formation of spherical NPs with a smooth surface, while the drug was amorphously dispersed within most of the prepared NPs, with the exemption of those systems contianing the CDs. Finally, in vitro dissolution release studies revealed that the prepared NPs could prolong GAL’s release for up to 12 days. In sum, regarding the most promising system, the results of the present study clearly suggest that the preparation of NPs using both Cys-CS and CDs results in a more thermodynamically stable drug dispersion, while a zero-order release profile was achieved, which is essential to attain a stable in vivo pharmacokinetic behavior.
format Online
Article
Text
id pubmed-9571213
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95712132022-10-17 L-Cysteine Modified Chitosan Nanoparticles and Carbon-Based Nanostructures for the Intranasal Delivery of Galantamine Nanaki, Stavroula G. Spyrou, Konstantinos Veneti, Pelagia Karouta, Niki Gournis, Dimitrios Baroud, Turki N. Barmpalexis, Panagiotis Bikiaris, Dimitrios N. Polymers (Basel) Article The present study evaluates the use of thiolized chitosan conjugates (CS) in combination with two fundamental carbon nanoforms (carbon dots (CDs) and Hierarchical Porous Carbons (HPC)) for the preparation of intranasally (IN) administrated galantamine (GAL) nanoparticles (NPs). Initially, the modification of CS with L-cysteine (Cys) was performed, and the successful formation of a Cys-CS conjugates was verified via (1)H-NMR, FTIR, and pXRD. The new Cys-CS conjugate showed a significant solubility enhancement in neutral and alkaline pH, improving CS’s utility as a matrix-carrier for IN drug administration. In a further step, drug-loaded NPs were prepared via solid-oil–water double emulsification, and thoroughly analyzed by SEM, DLS, FTIR and pXRD. The results showed the formation of spherical NPs with a smooth surface, while the drug was amorphously dispersed within most of the prepared NPs, with the exemption of those systems contianing the CDs. Finally, in vitro dissolution release studies revealed that the prepared NPs could prolong GAL’s release for up to 12 days. In sum, regarding the most promising system, the results of the present study clearly suggest that the preparation of NPs using both Cys-CS and CDs results in a more thermodynamically stable drug dispersion, while a zero-order release profile was achieved, which is essential to attain a stable in vivo pharmacokinetic behavior. MDPI 2022-09-24 /pmc/articles/PMC9571213/ /pubmed/36235952 http://dx.doi.org/10.3390/polym14194004 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nanaki, Stavroula G.
Spyrou, Konstantinos
Veneti, Pelagia
Karouta, Niki
Gournis, Dimitrios
Baroud, Turki N.
Barmpalexis, Panagiotis
Bikiaris, Dimitrios N.
L-Cysteine Modified Chitosan Nanoparticles and Carbon-Based Nanostructures for the Intranasal Delivery of Galantamine
title L-Cysteine Modified Chitosan Nanoparticles and Carbon-Based Nanostructures for the Intranasal Delivery of Galantamine
title_full L-Cysteine Modified Chitosan Nanoparticles and Carbon-Based Nanostructures for the Intranasal Delivery of Galantamine
title_fullStr L-Cysteine Modified Chitosan Nanoparticles and Carbon-Based Nanostructures for the Intranasal Delivery of Galantamine
title_full_unstemmed L-Cysteine Modified Chitosan Nanoparticles and Carbon-Based Nanostructures for the Intranasal Delivery of Galantamine
title_short L-Cysteine Modified Chitosan Nanoparticles and Carbon-Based Nanostructures for the Intranasal Delivery of Galantamine
title_sort l-cysteine modified chitosan nanoparticles and carbon-based nanostructures for the intranasal delivery of galantamine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571213/
https://www.ncbi.nlm.nih.gov/pubmed/36235952
http://dx.doi.org/10.3390/polym14194004
work_keys_str_mv AT nanakistavroulag lcysteinemodifiedchitosannanoparticlesandcarbonbasednanostructuresfortheintranasaldeliveryofgalantamine
AT spyroukonstantinos lcysteinemodifiedchitosannanoparticlesandcarbonbasednanostructuresfortheintranasaldeliveryofgalantamine
AT venetipelagia lcysteinemodifiedchitosannanoparticlesandcarbonbasednanostructuresfortheintranasaldeliveryofgalantamine
AT karoutaniki lcysteinemodifiedchitosannanoparticlesandcarbonbasednanostructuresfortheintranasaldeliveryofgalantamine
AT gournisdimitrios lcysteinemodifiedchitosannanoparticlesandcarbonbasednanostructuresfortheintranasaldeliveryofgalantamine
AT baroudturkin lcysteinemodifiedchitosannanoparticlesandcarbonbasednanostructuresfortheintranasaldeliveryofgalantamine
AT barmpalexispanagiotis lcysteinemodifiedchitosannanoparticlesandcarbonbasednanostructuresfortheintranasaldeliveryofgalantamine
AT bikiarisdimitriosn lcysteinemodifiedchitosannanoparticlesandcarbonbasednanostructuresfortheintranasaldeliveryofgalantamine